Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study-Reference-Cited by-同舟云学术

Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study

Published:2023-08 Issue: Volume:62 Page:102102
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Qassim Suelen H.,Chemaitelly Hiam,Ayoub Houssein H.^ORCID,Coyle Peter,Tang Patrick,Yassine Hadi M.,Al Thani Asmaa A.,Al-Khatib Hebah A.,Hasan Mohammad R.,Al-Kanaani Zaina,Al-Kuwari Einas,Jeremijenko Andrew,Kaleeckal Anvar Hassan,Latif Ali Nizar,Shaik Riyazuddin Mohammad,Abdul-Rahim Hanan F.,Nasrallah Gheyath K.,Al-Kuwari Mohamed Ghaith,Butt Adeel A.,Al-Romaihi Hamad Eid,Al-Thani Mohamed H.,Al-Khal Abdullatif,Bertollini Roberto,Abu-Raddad Laith J.^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference53 articles.

1. Effectiveness of the BNT162b2 Covid-19 vaccine against the B.1.1.7 and B.1.351 variants;Abu-Raddad;N Engl J Med,2021

2. mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar;Chemaitelly;Nat Med,2021

3. Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar;Chemaitelly;N Engl J Med,2021

4. Waning mRNA-1273 vaccine effectiveness against SARS-CoV-2 infection in Qatar;Abu-Raddad;N Engl J Med,2022

5. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression;Feikin;Lancet,2022

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Community-based COVID-19 vaccination services improve user satisfaction: findings from a large household survey in Bali Province, Indonesia;Australian Journal of Primary Health;2024-08-30

2. All-cause mortality according to COVID-19 vaccination status: An analysis of the UK office for National statistics public data;F1000Research;2024-08-05

3. Deployment of COVID-19 vaccine in the WHO Eastern Mediterranean Region 2021–23: How do we switch to a life course approach?;Vaccine;2024-06

4. Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands;AIDS;2024-05-28

5. Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient;Vaccine;2024-05